BACKGROUND: @entity1822 of the mesosigma is a very rare entity, with low 5-year survival rates. Treatment consists of resection of the @entity5 and, if applicable, of synchronous or metachronous metastases. Local treatment options for @entity3 should be exploited as long as possible, as response to chemotherapy is reportedly disappointing. Stereotactic radiotherapy is a fairly new locally effective treatment option which has been well established in stereotactic radiotherapy of @entity2 . Whether repeated stereotactic radiotherapy sessions for treatment of lung metastases can be safely and successfully performed over a long time period is not yet well documented. CASE REPORT: We present the case of a 71-year-old female @entity1 who had a primary diagnosis of lung metastases 12 years ago. Atypical resections of 4 lung metastases were performed in 2001 and 2002. Between 2004 and 2011, 7 sessions of stereotactic body irradiation of lung metastases were performed. All stereotactic treatment were tolerated well (no radiation @entity55 , FEV1 was 1.3 L [67.8%] in 2004 and 0.99 L [56.3%] in 2011). CONCLUSIONS: The present case could demonstrate that a repetitive treatment of lung metastases with multiple stereotactic radiotherapy sessions can lead to long-term survival with a good quality of life.

Long-term survival in metastasized XXXX : a case report and review of the literature.

@entity1 :: ('9606', 'Species') :: ['patient'] @entity55 :: ('MESH:D011014', 'Disease') :: ['pneumonitis'] @entity5 :: ('MESH:D009369', 'Disease') :: ['primary tumor'] @entity2 :: ('MESH:D008175', 'Disease') :: ['lung tumors'] @entity1822 :: ('MESH:D007890', 'Disease') :: ['Leiomyosarcoma'] @entity3 :: ('MESH:D009362', 'Disease') :: ['metastatic disease']
@entity1822 :: (MESH:D007890,Disease) :: ['leiomyosarcoma']
